Thank you for your continued support of Provectus in 2022. As fellow, longtime shareholders, our leadership team is committed to maximizing the long-term, fundamental value of the Company through the ...
KNOXVILLE, Tenn., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced a $3 ...
KNOXVILLE, Tenn., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. ("Provectus” or the "Company”) (OTCQB: PVCT) today announced a $3 million seed financing round for VisiRose, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results